3.1.2 - Recreational drugs at the synapse
Recreational drugs can change how messages pass between neurons in the central nervous system. This lesson explains receptor activation, receptor blockade and altered neurotransmitter removal, using nicotine, ketamine and cocaine as examples. Following the affected stage of transmission helps explain behaviour more accurately than calling every drug a chemical that simply “speeds up” or “slows down” the brain.
Activating or blocking a receptor
A drug can change neural communication by acting on the proteins that normally respond to neurotransmitters.
At a chemical synapse, an action potential causes the presynaptic terminal to release neurotransmitter. The messenger crosses the cleft and binds to receptors on the receiving cell. Receptor activation changes that cell's activity. A psychoactive drug is a substance that alters mental processes or behaviour through its effects on the nervous system. Different drugs can act at different stages of this communication.
Agonist and antagonist
A receptor agonist binds to and activates a receptor. A receptor antagonist reduces or prevents its activation or response. These terms describe actions at a particular receptor, rather than a drug's overall behavioural effect.
Nicotine acts as an agonist at nicotinic acetylcholine receptors. These receptors normally respond to acetylcholine; nicotine also activates them. They are ion channels, so activation can allow ions to flow and change neural activity. This influences several circuits, including pathways involved in dopamine release and reinforcement. Nicotine does not become acetylcholine, and it does not activate every kind of acetylcholine receptor. Repeated exposure can also change receptor responsiveness, so the immediate action is not the complete explanation of long-term use.
Ketamine provides a contrasting example: it antagonises NMDA receptors, a type of glutamate receptor. An important mechanism is blocking the receptor's ion channel, reducing current through it. This is not the same as occupying glutamate's binding site and preventing glutamate from attaching. Blocking this component of excitatory transmission can disturb the integration of information, contributing to dissociative effects: a changed sense of connection to one's body or surroundings. The mechanism is a useful example, rather than an account of every ketamine effect or every dose.
An agonist is not automatically a stimulant, and an antagonist is not automatically a sedative. Activating an inhibitory pathway can reduce activity in its target. Blocking an inhibitory influence can indirectly increase activity elsewhere. The receptor, cell and circuit determine the result.
Changing neurotransmitter removal
A drug can enhance a transmitter's action without directly activating its postsynaptic receptor.
After release, neurotransmitter must be removed or inactivated to limit the signal's duration. Reuptake transporters return some transmitters to the presynaptic neuron. Enzymes break down particular transmitters, and molecules can also diffuse away. A transporter is not a receptor: transporting a chemical out of the cleft and responding to it are different operations.
Cocaine blocks transporters for dopamine and other monoamine transmitters, including serotonin and noradrenaline. Blocking dopamine reuptake means released dopamine remains available outside cells for longer and can continue acting on dopamine receptors. In reinforcement-related pathways this helps explain increased reinforcement of drug-taking. The crucial sequence is transporter inhibition, reduced removal, increased transmitter availability, then altered receptor signalling. It is inaccurate to say that cocaine's central mechanism here is directly fitting into and activating dopamine receptors.
Suppose an illustrative substance stops an enzyme that normally breaks down a messenger. The messenger could remain active for longer because breakdown is reduced. That would be another way of altering the removal stage; it would not be evidence that the substance releases extra messenger or directly activates a receptor. No specific recreational enzyme inhibitor is required to understand this distinction.
The three verified examples can now be compared by their immediate targets:
| Example | Immediate action considered here | Consequence for signalling |
|---|---|---|
| Nicotine | Activates nicotinic acetylcholine receptors | Alters activity through those receptors |
| Ketamine | Blocks NMDA receptor-channel function | Reduces that component of glutamate signalling |
| Cocaine | Inhibits monoamine reuptake transporters | Extends availability of released transmitters |
These mechanisms are distinct, even when several drugs ultimately influence overlapping pathways. Describing the shared involvement of dopamine does not mean all drugs act directly on the same receptor.
Connecting a synaptic action to behaviour
A verified synaptic action explains part of a drug's behavioural effects, but it is not a complete account of a person's response.
Begin with the specific action, then connect it to a relevant circuit or process. For nicotine, receptor activation changes neural activity and can increase dopamine release in reinforcement pathways. Experiences associated with using the drug can then acquire motivational significance. For cocaine, prolonged transmitter availability changes signalling and can reinforce use. These links explain why repeating a behaviour may become more likely; they do not mean dopamine is a literal pleasure substance or that every exposure produces addiction.
Reinforcement means a consequence increases the future likelihood of a behaviour. It differs from simply finding something pleasant at one moment. A complete account of continued drug use also involves learning, cues, access, stress and social circumstances. These influences can interact with pharmacological actions rather than compete with them.
Synaptic explanations have a strength: a proposed molecular target can be investigated, making the explanation more precise than “the drug changes the mind”. For example, distinguishing a transporter blocker from a receptor agonist generates different predictions about which protein must be affected. However, the same drug can act at several targets and an acute effect can differ from changes after repeated use. Receptor adaptation and wider circuit changes mean that one diagram of one synapse cannot represent the entire history of drug use.
Individual response also depends on the amount reaching the brain, timing, other substances, physiology and experience. A fictional pair of people exposed to the same drug could show different behavioural responses without disproving the verified receptor mechanism. The mechanism concerns a biological action; it does not promise identical outcomes for all people.
Explain a drug by identifying its target, how signalling changes, and the relevant behavioural process. Keep claims about individuals within the evidence.
Research can test receptor or transporter effects in controlled preparations, but complex human behaviour needs additional evidence. A difference in drug use between two groups does not by itself identify a neurotransmitter cause. The scientific conclusion should match what was measured and controlled. These examples explain transmission; they are not instructions to experiment with drugs or recommendations about treatment.